Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

No endocrine safety concerns noted in phase II trials of ulipristal acetate for uterine fibroids

April 28, 2010

Greater HbA1c reductions with LY-2189265 in Hispanic patients with type 2 diabetes

April 28, 2010

GlaxoSmithKline presents new calcium receptor antagonists

April 27, 2010

GSK discloses new calcium-sensing receptor antagonists

April 26, 2010

Amylin, Lilly and Alkermes reply to FDA's complete response letter on Bydureon

April 23, 2010

Nuon advances NU-1618 to phase IIb for chronic hyperuricemia in gout

April 23, 2010

Dainippon Sumitomo set to launch Metgluco in Japan

April 23, 2010

Lipocine earns milestone payment from Abbott for oral testosterone product

April 23, 2010

Merck & Co. presents new CETP inhibitor prodrugs for hypercholesterolemia

April 23, 2010

Dutogliptin reduces HbA1c in phase III trial in type 2 diabetes

April 22, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Fauci’s silence may put him in contempt of Congress
BioWorld
After repeatedly invoking the Fifth Amendment to every question asked during the July 29 hearing of the U.S. Senate Homeland Security Committee, Anthony Fauci,...